UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053549
Receipt number R000061108
Scientific Title Examination of cerebral blood flow changes during food image presentation using fMRI
Date of disclosure of the study information 2024/07/01
Last modified on 2024/08/06 09:05:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of cerebral blood flow changes during food image presentation using fMRI

Acronym

Examination of cerebral blood flow changes during food image presentation using fMRI

Scientific Title

Examination of cerebral blood flow changes during food image presentation using fMRI

Scientific Title:Acronym

Examination of cerebral blood flow changes during food image presentation using fMRI

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the changes in cerebral blood flow in food image presentation after eating test food

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change of cerebral blood flow

Key secondary outcomes

Questionnaire on palatability and feelings toward test foods


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

test food, Single intake

Interventions/Control_2

test food, Single intake

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

39 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Subjects who have experience of eating complex frozen desserts and like them
2)Subjects who have received fMRI
3)Right handed person
4)Healthy and free of chronic diseases
5)Subjects who have received explanation and understood about this study, and who can consent to the content on the informed consent documents.
6)Subjects who can come to the venue on the designated day and take measurements

Key exclusion criteria

1)Individuals using medical products.
2)Subjects whose medical history cannot be determined to have no effect on study participation
3)Subjects with alcoholism or a mental illness.
4)Subjects who used or applied a drug for treatment of disease in the past 1 month.
5)Subjects with food allergy.
6)Subjects who are a smoker.
7)Females who are or are possibly pregnant, or lactating.
8)Subjects who have had brain surgery or have brain disease
9)Claustrophobic
10)Subjects with tattoos
11)Subjects who have undergone correction or implants, and who have metal in their bodies such as metal plates or screws for prosthesis such as fractures.
12)Subjects who were hospitalized and received treatment in the past 6 months.
13)Subjects who participated in other clinical studies within three month of consent for participation in this study.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Masato
Middle name
Last name Kawamoto

Organization

Morinaga & Co., Ltd.

Division name

R&D institute

Zip code

230-8504

Address

2-1-1, Shimosueyoshi, Tsurumi-ku, Yokohama

TEL

045-571-6140

Email

m-kawamoto-hf@morinaga.co.jp


Public contact

Name of contact person

1st name Takayuki
Middle name
Last name Yamamoto

Organization

Morinaga & Co., Ltd.

Division name

Health Science and Research Center, R&D institute

Zip code

230-8504

Address

2-1-1, Shimosueyoshi, Tsurumi-ku, Yokohama, Kanagawa

TEL

045-571-6140

Homepage URL


Email

t-yamamoto-jc@morinaga.co.jp


Sponsor or person

Institute

Morinaga & Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Morinaga & Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Building 6F, 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 11 Month 29 Day

Date of IRB

2023 Year 12 Month 07 Day

Anticipated trial start date

2024 Year 01 Month 05 Day

Last follow-up date

2024 Year 02 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 02 Month 06 Day

Last modified on

2024 Year 08 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061108